Analysis BioTech Drug Development Telehealth 
Healthcare IT Today
JANUARY 8, 2024
Given the improvements in costs, trial sponsors can now take advantage of these exchanges at scale and leverage the data for both pre-screening and health economic analysis. As DCTs and virtual site acceptance accelerates, a knock-on effect will be that more of these trials will include HEOR analysis. Dave Latshaw, CEO at BioPhy 1.
Digital Health Global
NOVEMBER 20, 2023
Drawing on AstraZeneca’s deep experience of developing novel therapeutics and with insights from thousands of patients and clinical researchers, Evinova will provide established technology solutions to pharma, biotech and CROs to support clinical research globally. Available at: [link]. Accessed November 2023.
Expert insights. Personalized for you.
85 
Let's personalize your content